4//SEC Filing
THEUER CHARLES 4
Accession 0001209191-23-025930
CIK 0001394319other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 6:00 AM ET
Size
7.0 KB
Accession
0001209191-23-025930
Insider Transaction Report
Form 4
THEUER CHARLES
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-04-27$0.75/sh+47,000$35,250→ 399,417 total - Purchase
Common Stock
2023-04-26$0.66/sh+3,999$2,639→ 352,417 total
Footnotes (2)
- [F1]Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.7596, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
Tracon Pharmaceuticals, Inc.
CIK 0001394319
Entity typeother
Related Parties
1- filerCIK 0001631338
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 6:00 AM ET
- Size
- 7.0 KB